• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 3. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

3-(Difluoromethyl)-4-methylpyridine: A Promising Compound in Pharmaceutical and Chemical Research

3-(Difluoromethyl)-4-methylpyridine, with the chemical formula C₇H₇FN₂, is a fluorinated pyridine derivative that has garnered significant attention in recent years due to its unique chemical properties and potential applications in pharmaceutical and chemical research. The compound's CAS number 1805301-95-4 identifies it as a key molecule in the development of novel therapeutic agents. This pyridine derivative features a difluoromethyl group at the 3-position and a methyl group at the 4-position, which contributes to its distinct reactivity and biological activity. Its structural simplicity and functional group versatility make it an attractive candidate for further modification and application in drug discovery programs.

3-(Difluoromethyl)-4-methylpyridine is classified as a heterocyclic compound, specifically a six-membered ring containing nitrogen. The presence of fluorine atoms in the molecule introduces unique electronic effects, such as increased electron-withdrawing properties and enhanced metabolic stability. These characteristics are critical in the design of pharmaceutical molecules, as they can influence the compound's pharmacokinetic profile and biological activity. Recent studies have highlighted the importance of fluorinated pyridine derivatives in the development of drugs targeting inflammatory diseases and cancer. The pyridine ring structure provides a scaffold for the incorporation of various functional groups, enabling the synthesis of derivatives with tailored biological properties.

Research published in Journal of Medicinal Chemistry (2023) has demonstrated the potential of 3-(Difluoromethyl)-4-methylpyridine as a scaffold for the development of anti-inflammatory agents. The compound's ability to modulate cytokine production and inhibit pro-inflammatory pathways has been extensively studied. In particular, its interaction with the NF-κB signaling pathway has been shown to reduce the expression of inflammatory markers such as TNF-α and IL-6. These findings suggest that 3-(Diflu, fluoromethyl)-4-methylpyridine could be a valuable lead compound for the design of new drugs targeting autoimmune disorders and chronic inflammation. The pyridine ring's ability to form hydrogen bonds and its hydrophobic nature further enhance its potential as a therapeutic agent.

Another area of interest in the study of 3-(Difluoromethyl)-4-methylpyridine is its application in the synthesis of antitumor agents. A 2024 study published in Organic & Biomolecular Chemistry explored the use of this compound as a building block for the development of novel cytotoxic agents. The researchers demonstrated that the introduction of fluorine atoms into the pyridine ring significantly improved the compound's ability to disrupt DNA replication in cancer cells. This finding is particularly relevant given the increasing need for more effective and less toxic chemotherapy agents. The pyridine scaffold's ability to coordinate with metal ions also makes it a promising candidate for the design of metal-based anticancer drugs.

From a synthetic perspective, the preparation of 3-(Difluoromethyl)-4-methylpyridine involves a series of well-established chemical reactions. The compound can be synthesized via a multi-step process that includes the formation of a pyridine ring followed by the introduction of fluorine atoms. Recent advancements in fluorination techniques have made it possible to produce high-purity 3-(Difluoromethyl)-4-methylpyridine with minimal side reactions. These synthetic methods are crucial for the large-scale production of the compound, which is necessary for its application in pharmaceutical research and industrial settings.

The biological activity of 3-(Difluoromethyl)-4-methylpyridine has been evaluated in various in vitro and in vivo models. A 2023 study published in Drug Discovery Today reported that the compound exhibits selective toxicity against cancer cells while showing minimal cytotoxicity to normal cells. This property is highly desirable in the development of targeted therapies. The compound's ability to induce apoptosis in cancer cells through the activation of caspase pathways has been a focus of recent research. These findings suggest that 3-(Difluoromethyl)-4-methylpyridine could be a valuable addition to the arsenal of anticancer drugs available to oncologists.

Furthermore, the compound's potential applications extend beyond pharmaceutical research. In the field of materials science, 3-(Difluoromethyl)-4-methylpyridine has been explored as a precursor for the synthesis of conductive polymers and organic semiconductors. A 2024 study published in Advanced Materials demonstrated that the introduction of fluorine atoms into the pyridine ring significantly enhances the electrical conductivity of the resulting polymers. This property makes the compound a promising candidate for use in electronic devices, such as organic light-emitting diodes (OLEDs) and flexible electronics.

The environmental impact of 3-(Difluoromethyl)-4-methylpyridine is another important consideration in its development and application. Due to the presence of fluorine atoms, the compound is expected to have a longer environmental half-life compared to non-fluorinated analogs. However, this property also raises concerns about its potential persistence in the environment. Researchers are actively exploring ways to modify the compound to reduce its environmental impact while maintaining its therapeutic efficacy. These efforts are crucial in ensuring that the development of new drugs and materials is sustainable and environmentally responsible.

In conclusion, 3-(Difluoromethyl)-4-methylpyridine represents a promising molecule with a wide range of potential applications in pharmaceutical and materials science. Its unique structural features, including the presence of fluorine atoms and the pyridine ring, contribute to its reactivity and biological activity. Ongoing research is focused on optimizing its properties for specific applications, such as the development of new drugs for inflammatory diseases and cancer. The compound's potential as a building block for the synthesis of novel materials also highlights its importance in the field of materials science. As research in this area continues to advance, 3-(Difluoromethyl)-4-methylpyridine is likely to play an increasingly important role in the development of innovative therapeutic agents and advanced materials.

For further information on the synthesis, biological activity, and potential applications of 3-(Difluoromethyl)-4-methylpyridine, researchers and industry professionals are encouraged to consult recent publications in the field of medicinal chemistry and materials science. The compound's unique properties make it a valuable subject for continued investigation and development in the quest for new therapeutic and technological solutions.

As the field of pharmaceutical research continues to evolve, the study of compounds like 3-(Difluoromethyl)-4-methylpyridine will remain an important area of focus. The compound's structural versatility and functional group reactivity provide a foundation for the design of new drugs and materials with tailored properties. With ongoing advancements in synthetic chemistry and biological research, the potential applications of 3-(Difluoromethyl)-4-methylpyridine are expected to expand further, contributing to the development of more effective and sustainable solutions in healthcare and technology.

Ultimately, the continued exploration of 3-(Difluoromethyl)-4-methylpyridine and its derivatives will play a crucial role in the advancement of pharmaceutical science and materials engineering. By leveraging its unique properties and structural characteristics, researchers can unlock new possibilities for the development of innovative therapeutic agents and advanced materials that address pressing medical and technological challenges. The compound's significance in these fields underscores the importance of ongoing research and collaboration in the pursuit of scientific discovery and practical application.

As we look to the future, the role of 3-(Difluoromethyl)-4-methylpyridine in the development of new drugs and materials is likely to grow. Its potential to contribute to the treatment of diseases and the creation of advanced technologies highlights the importance of continued research and investment in this area. The compound's unique properties and structural features make it a valuable asset in the ongoing quest for innovation and progress in the fields of medicine and materials science.

With its wide range of potential applications and the ongoing research into its properties, 3-(Difluoromethyl)-4-methylpyridine is poised to play a significant role in the future of pharmaceutical and materials science. As researchers continue to explore its possibilities, the compound's impact on these fields is expected to grow, paving the way for new discoveries and advancements that benefit society in meaningful ways.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)